Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 12.85
+0.14 (1.10%)
At close: Sep 30, 2025
Newland Pharmaceutical Market Cap
Newland Pharmaceutical has a market cap or net worth of 5.04 billion as of October 1, 2025. Its market cap has increased by 44.73% in one year.
Market Cap
5.04B
Enterprise Value
4.38B
Revenue
688.48M
Ranking
n/a
PE Ratio
35.57
Stock Price
12.85
Market Cap Chart
Since November 16, 2022, Newland Pharmaceutical's market cap has decreased from 5.31B to 5.04B, a decrease of -5.08%. That is a compound annual growth rate of -1.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 5.04B | 30.08% |
| Dec 31, 2024 | 3.87B | -6.96% |
| Dec 29, 2023 | 4.16B | 8.12% |
| Dec 30, 2022 | 3.85B | -27.46% |
| Nov 16, 2022 | 5.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 460.94B |
| WuXi AppTec | 306.30B |
| Shenzhen Mindray Bio-Medical Electronics | 289.04B |
| Sichuan Biokin Pharmaceutical | 145.50B |
| Shanghai United Imaging Healthcare | 121.28B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.41B |
| Aier Eye Hospital Group | 115.45B |
| Yunnan Baiyao Group Co.,Ltd | 102.35B |